Side effects of Dabrafenib and Vemurafenib include decreased appetite, headache, cough, nausea, emesis and/or diarrhea and joint pain. Skin cancer incidence increases upon treatment with BRAF inhibitors. The gene discussed is BRAF; the disease is skin neoplasm.